OBLN

Obalon Therapeutics (OBLN)

Obalon Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:OBLN

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2023/05/16	19 : 02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:OBLN	Obalon Therapeutics Inc
2023/05/16	06 : 07	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:OBLN	Obalon Therapeutics Inc
2023/04/27	05 : 07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:OBLN	Obalon Therapeutics Inc
2023/04/24	22 : 07	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:OBLN	Obalon Therapeutics Inc
2023/04/14	06 : 25	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:OBLN	Obalon Therapeutics Inc
2023/04/04	06 : 12	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	NASDAQ:OBLN	Obalon Therapeutics Inc
2023/03/22	05 : 19	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:OBLN	Obalon Therapeutics Inc
2023/03/18	06 : 02	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	NASDAQ:OBLN	Obalon Therapeutics Inc
2023/02/15	03 : 25	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:OBLN	Obalon Therapeutics Inc
2023/02/11	06 : 07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:OBLN	Obalon Therapeutics Inc
2023/02/08	23 : 02	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)	NASDAQ:OBLN	Obalon Therapeutics Inc
2023/02/03	23 : 02	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	NASDAQ:OBLN	Obalon Therapeutics Inc
2023/02/03	20 : 05	Edgar (US Regulatory)	Withdrawal of a Registration Statement Withdrawal Request (rw Wd)	NASDAQ:OBLN	Obalon Therapeutics Inc
2023/02/02	20 : 01	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	NASDAQ:OBLN	Obalon Therapeutics Inc
2023/01/27	20 : 02	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	NASDAQ:OBLN	Obalon Therapeutics Inc
2023/01/13	07 : 10	Edgar (US Regulatory)	Securities Registration Statement (s-1)	NASDAQ:OBLN	Obalon Therapeutics Inc
2022/12/21	07 : 31	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:OBLN	Obalon Therapeutics Inc
2022/12/21	06 : 36	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OBLN	Obalon Therapeutics Inc
2022/11/15	07 : 27	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:OBLN	Obalon Therapeutics Inc
2022/11/11	06 : 56	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:OBLN	Obalon Therapeutics Inc
2022/11/11	06 : 13	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OBLN	Obalon Therapeutics Inc
2022/11/01	05 : 03	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NASDAQ:OBLN	Obalon Therapeutics Inc
2022/08/27	05 : 22	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:OBLN	Obalon Therapeutics Inc
2022/08/16	19 : 06	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:OBLN	Obalon Therapeutics Inc
2022/08/16	19 : 03	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	NASDAQ:OBLN	Obalon Therapeutics Inc
2022/08/12	05 : 31	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OBLN	Obalon Therapeutics Inc
2022/08/03	05 : 10	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:OBLN	Obalon Therapeutics Inc
2022/07/22	05 : 07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:OBLN	Obalon Therapeutics Inc
2022/06/07	05 : 58	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OBLN	Obalon Therapeutics Inc
2022/06/07	05 : 50	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OBLN	Obalon Therapeutics Inc